# Cognitive Effects of Immunomodulatory Drugs in MS

> **NCT00229502** · — · COMPLETED · sponsor: **Sharon Lynch, MD** · enrollment: 96 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00229502
- **Lead sponsor:** Sharon Lynch, MD
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2011-09
- **Final completion:** 2011-12
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2012-03-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00229502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00229502, "Cognitive Effects of Immunomodulatory Drugs in MS". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00229502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*